<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF95163E-02EC-4889-A6AE-88F3503BA786"><gtr:id>FF95163E-02EC-4889-A6AE-88F3503BA786</gtr:id><gtr:name>Government of France</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/665A34CB-4ED4-40A0-8070-BD590E7EB42B"><gtr:id>665A34CB-4ED4-40A0-8070-BD590E7EB42B</gtr:id><gtr:name>UK Biobank</gtr:name><gtr:address><gtr:line1>1-2 Spectrum Way</gtr:line1><gtr:line2>Adswood</gtr:line2><gtr:postCode>SK3 0SA</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8F2AA65-FB13-45D8-96BA-E478CE387554"><gtr:id>A8F2AA65-FB13-45D8-96BA-E478CE387554</gtr:id><gtr:name>Karolinska University Hospital</gtr:name><gtr:address><gtr:line1>Karolinska University Hospital</gtr:line1><gtr:line2>Huddinge</gtr:line2><gtr:postCode>SE 141 86</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DFBABDBD-1EE6-4125-96A9-35DDA31FBAF8"><gtr:id>DFBABDBD-1EE6-4125-96A9-35DDA31FBAF8</gtr:id><gtr:name>Federal Ministry of Science, Research and Economy (BMWFW)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EC177B1F-35EE-4B74-981D-E8382EE3D18C"><gtr:id>EC177B1F-35EE-4B74-981D-E8382EE3D18C</gtr:id><gtr:name>London School of Economics &amp; Pol Sci</gtr:name><gtr:address><gtr:line1>Houghton Street</gtr:line1><gtr:line2>Aldwych</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC2A 2AE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/01128021-52EB-4EFB-B0E5-437538E9F785"><gtr:id>01128021-52EB-4EFB-B0E5-437538E9F785</gtr:id><gtr:name>Almirall</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A3F0E7CF-8EB7-43CB-BF51-DF1B3AE5C6DD"><gtr:id>A3F0E7CF-8EB7-43CB-BF51-DF1B3AE5C6DD</gtr:id><gtr:name>Lundbeck Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DA520CA9-17B1-4166-A89C-915E6A74BFE3"><gtr:id>DA520CA9-17B1-4166-A89C-915E6A74BFE3</gtr:id><gtr:name>Norwegian Institute of Public Health</gtr:name><gtr:address><gtr:line1>Norwegian Institute of Public Health</gtr:line1><gtr:line2>PO Box 4404 Nydalen</gtr:line2><gtr:postCode>N-0403</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/931F0B0D-E479-4E31-AF94-5CCAFB6A4445"><gtr:id>931F0B0D-E479-4E31-AF94-5CCAFB6A4445</gtr:id><gtr:name>deCODE Genetics</gtr:name><gtr:address><gtr:line1>Sturlugata 8</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4320E3F8-C34A-4CB6-9C13-726ABEFC298F"><gtr:id>4320E3F8-C34A-4CB6-9C13-726ABEFC298F</gtr:id><gtr:name>National Institute for Cancer Research, Genoa (IST) (Istituto Nazionale per la Ricerca sul Cancro di Genova)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5ABC79A-9634-458E-BD8B-089286716664"><gtr:id>D5ABC79A-9634-458E-BD8B-089286716664</gtr:id><gtr:name>Academy of Athens</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CA59D75D-1AD9-4235-8F35-4E7E6E68EB81"><gtr:id>CA59D75D-1AD9-4235-8F35-4E7E6E68EB81</gtr:id><gtr:name>Norwegian University of Science and Technology (NTNU)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/681C1535-3857-4B97-ADE1-82DBD84698A4"><gtr:id>681C1535-3857-4B97-ADE1-82DBD84698A4</gtr:id><gtr:name>Italian National Health Service</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BDF36443-7BBF-442D-B7DF-90862772B70C"><gtr:id>BDF36443-7BBF-442D-B7DF-90862772B70C</gtr:id><gtr:name>Government of the Netherlands</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/92B81E1C-B58D-4789-A544-BD07D637286F"><gtr:id>92B81E1C-B58D-4789-A544-BD07D637286F</gtr:id><gtr:name>University of Klagenfurt</gtr:name><gtr:address><gtr:line1>Schottenfeldgasse 29</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DA0437CC-F637-41CB-8544-DFA50F04360C"><gtr:id>DA0437CC-F637-41CB-8544-DFA50F04360C</gtr:id><gtr:name>National Research Council CNR - Italy</gtr:name><gtr:address><gtr:line1>National Research Council CNR</gtr:line1><gtr:line2>P le Aldo Moro 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6965F193-D7C9-499B-8CE2-0C573BBAA4DD"><gtr:id>6965F193-D7C9-499B-8CE2-0C573BBAA4DD</gtr:id><gtr:name>The Icelandic Centre for Research (RANN?S)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F090453F-0566-49B4-B11F-BD6B73A64E03"><gtr:id>F090453F-0566-49B4-B11F-BD6B73A64E03</gtr:id><gtr:name>University of Vienna</gtr:name><gtr:address><gtr:line1>Dr-Karl-L?ger-Ring 1</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48248E4C-A084-4BFD-864A-CDAA5513BA7B"><gtr:id>48248E4C-A084-4BFD-864A-CDAA5513BA7B</gtr:id><gtr:name>Molecular Medicine Ireland</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0BACE25-B55C-4EDF-B5EF-2E48E933C631"><gtr:id>A0BACE25-B55C-4EDF-B5EF-2E48E933C631</gtr:id><gtr:name>University of Tartu</gtr:name><gtr:address><gtr:line1>Ulikooli 18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Estonia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1A60B063-E58F-4072-A2EA-8474BE302464"><gtr:id>1A60B063-E58F-4072-A2EA-8474BE302464</gtr:id><gtr:name>International Agency for Research on Cancer (IARC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C6BEF6ED-BF47-40E2-917A-4FF3149DE30B"><gtr:id>C6BEF6ED-BF47-40E2-917A-4FF3149DE30B</gtr:id><gtr:name>German Federal Ministry of Education and Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CA10F5D0-8E26-4790-BF21-025009DDA322"><gtr:id>CA10F5D0-8E26-4790-BF21-025009DDA322</gtr:id><gtr:name>Medical University of Graz</gtr:name><gtr:address><gtr:line1>Harrachgasse 21</gtr:line1><gtr:line4>Graz</gtr:line4><gtr:line5>A-8010</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Austria</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/55E3189A-E372-4C13-AD98-87C6C754D4B3"><gtr:id>55E3189A-E372-4C13-AD98-87C6C754D4B3</gtr:id><gtr:name>Babraham Bioscience Technologies</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7834FF12-A0B3-48E0-BA8C-39F517E844C4"><gtr:id>7834FF12-A0B3-48E0-BA8C-39F517E844C4</gtr:id><gtr:name>Government of Estonia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/99E936B6-D5CB-477B-8E15-F6F0465C8967"><gtr:id>99E936B6-D5CB-477B-8E15-F6F0465C8967</gtr:id><gtr:name>Autonomous University of Madrid (UAM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E594C221-4738-4152-9CFD-57F6EB31C620"><gtr:id>E594C221-4738-4152-9CFD-57F6EB31C620</gtr:id><gtr:name>Fraunhofer Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F505561F-C42A-4559-96A1-DB13B5B06324"><gtr:id>F505561F-C42A-4559-96A1-DB13B5B06324</gtr:id><gtr:name>Telethon Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82885B82-50BA-40DE-B7A7-62CAF220EC58"><gtr:id>82885B82-50BA-40DE-B7A7-62CAF220EC58</gtr:id><gtr:name>General Secretariat For Research &amp; Technology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/00866200-F62B-429B-BF02-A0A841684ED5"><gtr:id>00866200-F62B-429B-BF02-A0A841684ED5</gtr:id><gtr:name>University of Salamanca</gtr:name><gtr:address><gtr:line1>Universidad de Salamanca</gtr:line1><gtr:line2>Patio de Escuelas 1</gtr:line2><gtr:line4>Salamanca</gtr:line4><gtr:line5>37071</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D3CC600D-1AD4-4272-99C1-158BDF55308C"><gtr:id>D3CC600D-1AD4-4272-99C1-158BDF55308C</gtr:id><gtr:name>Alliance Against Cancer</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3F817F1C-4D4C-4325-A83C-601A871E5487"><gtr:id>3F817F1C-4D4C-4325-A83C-601A871E5487</gtr:id><gtr:name>ORION Pharma</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6928AD0A-07BA-4B4C-8077-EDC03D56B3B8"><gtr:id>6928AD0A-07BA-4B4C-8077-EDC03D56B3B8</gtr:id><gtr:name>Netherlands Organisation for Health Research and Development</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3D2D81D-2671-410B-9D1C-BBBBDA8CF466"><gtr:id>E3D2D81D-2671-410B-9D1C-BBBBDA8CF466</gtr:id><gtr:name>Johnson &amp; Johnson Ltd</gtr:name><gtr:address><gtr:line1>Foundation Park</gtr:line1><gtr:line2>Roxborough Way</gtr:line2><gtr:line4>Maidenhead</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>SLG 3UG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1CC23DC2-3991-4123-B5F2-83C1F5793403"><gtr:id>1CC23DC2-3991-4123-B5F2-83C1F5793403</gtr:id><gtr:name>F. Hoffmann-La Roche AG</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ADD77807-7B00-4A41-A7A4-09A5D0BB801C"><gtr:id>ADD77807-7B00-4A41-A7A4-09A5D0BB801C</gtr:id><gtr:name>Esteve</gtr:name><gtr:address><gtr:line1>Avda. Mare de Deu de Montserrat, 221</gtr:line1><gtr:postCode>E-08041</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E777F7E-8B7E-406A-87FB-39A7026F891F"><gtr:id>4E777F7E-8B7E-406A-87FB-39A7026F891F</gtr:id><gtr:name>Uppsala University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/712757B9-CD96-4383-A0F9-F0D7F1B4951C"><gtr:id>712757B9-CD96-4383-A0F9-F0D7F1B4951C</gtr:id><gtr:name>Vitro (Biobanking services)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/98C379BE-5412-4C64-9838-F46315C76505"><gtr:id>98C379BE-5412-4C64-9838-F46315C76505</gtr:id><gtr:name>Health Research Board (HRB)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6A5D0F02-E386-44C0-BBAE-17AAC62AF2BA"><gtr:id>6A5D0F02-E386-44C0-BBAE-17AAC62AF2BA</gtr:id><gtr:name>Netherlands Federation of University Medical Centres (NFU)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E65D5505-6DF9-4801-9019-B9EDE5D0EE5D"><gtr:id>E65D5505-6DF9-4801-9019-B9EDE5D0EE5D</gtr:id><gtr:name>University Medical Center Gronigen</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6C747631-6855-48CC-BF64-0316AABB5DF8"><gtr:id>6C747631-6855-48CC-BF64-0316AABB5DF8</gtr:id><gtr:name>University of Malta</gtr:name><gtr:address><gtr:line1>Administration Bldg</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/61D20CC7-787C-455B-936A-3E16D0122205"><gtr:id>61D20CC7-787C-455B-936A-3E16D0122205</gtr:id><gtr:name>Semmelweis University</gtr:name><gtr:address><gtr:line1>Semmelweis University</gtr:line1><gtr:line2>Alkotas u. 44</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/620DB27D-4014-4278-AAD1-11105CC6BDEA"><gtr:id>620DB27D-4014-4278-AAD1-11105CC6BDEA</gtr:id><gtr:name>Novo Nordisk</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5A8C32C1-29FC-4B3A-8C07-C792DC7AF31B"><gtr:id>5A8C32C1-29FC-4B3A-8C07-C792DC7AF31B</gtr:id><gtr:name>Legal Pathways Institute for Health and Bio-Law</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5F32098B-3CD7-41E1-BD83-220F3383C071"><gtr:id>5F32098B-3CD7-41E1-BD83-220F3383C071</gtr:id><gtr:name>Spanish Ministry of Science and Innovation</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF95163E-02EC-4889-A6AE-88F3503BA786"><gtr:id>FF95163E-02EC-4889-A6AE-88F3503BA786</gtr:id><gtr:name>Government of France</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/665A34CB-4ED4-40A0-8070-BD590E7EB42B"><gtr:id>665A34CB-4ED4-40A0-8070-BD590E7EB42B</gtr:id><gtr:name>UK Biobank</gtr:name><gtr:address><gtr:line1>1-2 Spectrum Way</gtr:line1><gtr:line2>Adswood</gtr:line2><gtr:postCode>SK3 0SA</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8F2AA65-FB13-45D8-96BA-E478CE387554"><gtr:id>A8F2AA65-FB13-45D8-96BA-E478CE387554</gtr:id><gtr:name>Karolinska University Hospital</gtr:name><gtr:address><gtr:line1>Karolinska University Hospital</gtr:line1><gtr:line2>Huddinge</gtr:line2><gtr:postCode>SE 141 86</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DFBABDBD-1EE6-4125-96A9-35DDA31FBAF8"><gtr:id>DFBABDBD-1EE6-4125-96A9-35DDA31FBAF8</gtr:id><gtr:name>Federal Ministry of Science, Research and Economy (BMWFW)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC177B1F-35EE-4B74-981D-E8382EE3D18C"><gtr:id>EC177B1F-35EE-4B74-981D-E8382EE3D18C</gtr:id><gtr:name>London School of Economics &amp; Pol Sci</gtr:name><gtr:address><gtr:line1>Houghton Street</gtr:line1><gtr:line2>Aldwych</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC2A 2AE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/01128021-52EB-4EFB-B0E5-437538E9F785"><gtr:id>01128021-52EB-4EFB-B0E5-437538E9F785</gtr:id><gtr:name>Almirall</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A3F0E7CF-8EB7-43CB-BF51-DF1B3AE5C6DD"><gtr:id>A3F0E7CF-8EB7-43CB-BF51-DF1B3AE5C6DD</gtr:id><gtr:name>Lundbeck Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DA520CA9-17B1-4166-A89C-915E6A74BFE3"><gtr:id>DA520CA9-17B1-4166-A89C-915E6A74BFE3</gtr:id><gtr:name>Norwegian Institute of Public Health</gtr:name><gtr:address><gtr:line1>Norwegian Institute of Public Health</gtr:line1><gtr:line2>PO Box 4404 Nydalen</gtr:line2><gtr:postCode>N-0403</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/931F0B0D-E479-4E31-AF94-5CCAFB6A4445"><gtr:id>931F0B0D-E479-4E31-AF94-5CCAFB6A4445</gtr:id><gtr:name>deCODE Genetics</gtr:name><gtr:address><gtr:line1>Sturlugata 8</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4320E3F8-C34A-4CB6-9C13-726ABEFC298F"><gtr:id>4320E3F8-C34A-4CB6-9C13-726ABEFC298F</gtr:id><gtr:name>National Institute for Cancer Research, Genoa (IST) (Istituto Nazionale per la Ricerca sul Cancro di Genova)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5ABC79A-9634-458E-BD8B-089286716664"><gtr:id>D5ABC79A-9634-458E-BD8B-089286716664</gtr:id><gtr:name>Academy of Athens</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CA59D75D-1AD9-4235-8F35-4E7E6E68EB81"><gtr:id>CA59D75D-1AD9-4235-8F35-4E7E6E68EB81</gtr:id><gtr:name>Norwegian University of Science and Technology (NTNU)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/681C1535-3857-4B97-ADE1-82DBD84698A4"><gtr:id>681C1535-3857-4B97-ADE1-82DBD84698A4</gtr:id><gtr:name>Italian National Health Service</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BDF36443-7BBF-442D-B7DF-90862772B70C"><gtr:id>BDF36443-7BBF-442D-B7DF-90862772B70C</gtr:id><gtr:name>Government of the Netherlands</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/92B81E1C-B58D-4789-A544-BD07D637286F"><gtr:id>92B81E1C-B58D-4789-A544-BD07D637286F</gtr:id><gtr:name>University of Klagenfurt</gtr:name><gtr:address><gtr:line1>Schottenfeldgasse 29</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DA0437CC-F637-41CB-8544-DFA50F04360C"><gtr:id>DA0437CC-F637-41CB-8544-DFA50F04360C</gtr:id><gtr:name>National Research Council CNR - Italy</gtr:name><gtr:address><gtr:line1>National Research Council CNR</gtr:line1><gtr:line2>P le Aldo Moro 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6965F193-D7C9-499B-8CE2-0C573BBAA4DD"><gtr:id>6965F193-D7C9-499B-8CE2-0C573BBAA4DD</gtr:id><gtr:name>The Icelandic Centre for Research (RANN?S)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F090453F-0566-49B4-B11F-BD6B73A64E03"><gtr:id>F090453F-0566-49B4-B11F-BD6B73A64E03</gtr:id><gtr:name>University of Vienna</gtr:name><gtr:address><gtr:line1>Dr-Karl-L?ger-Ring 1</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48248E4C-A084-4BFD-864A-CDAA5513BA7B"><gtr:id>48248E4C-A084-4BFD-864A-CDAA5513BA7B</gtr:id><gtr:name>Molecular Medicine Ireland</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0BACE25-B55C-4EDF-B5EF-2E48E933C631"><gtr:id>A0BACE25-B55C-4EDF-B5EF-2E48E933C631</gtr:id><gtr:name>University of Tartu</gtr:name><gtr:address><gtr:line1>Ulikooli 18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Estonia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1A60B063-E58F-4072-A2EA-8474BE302464"><gtr:id>1A60B063-E58F-4072-A2EA-8474BE302464</gtr:id><gtr:name>International Agency for Research on Cancer (IARC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C6BEF6ED-BF47-40E2-917A-4FF3149DE30B"><gtr:id>C6BEF6ED-BF47-40E2-917A-4FF3149DE30B</gtr:id><gtr:name>German Federal Ministry of Education and Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CA10F5D0-8E26-4790-BF21-025009DDA322"><gtr:id>CA10F5D0-8E26-4790-BF21-025009DDA322</gtr:id><gtr:name>Medical University of Graz</gtr:name><gtr:address><gtr:line1>Harrachgasse 21</gtr:line1><gtr:line4>Graz</gtr:line4><gtr:line5>A-8010</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Austria</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/55E3189A-E372-4C13-AD98-87C6C754D4B3"><gtr:id>55E3189A-E372-4C13-AD98-87C6C754D4B3</gtr:id><gtr:name>Babraham Bioscience Technologies</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7834FF12-A0B3-48E0-BA8C-39F517E844C4"><gtr:id>7834FF12-A0B3-48E0-BA8C-39F517E844C4</gtr:id><gtr:name>Government of Estonia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/99E936B6-D5CB-477B-8E15-F6F0465C8967"><gtr:id>99E936B6-D5CB-477B-8E15-F6F0465C8967</gtr:id><gtr:name>Autonomous University of Madrid (UAM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E594C221-4738-4152-9CFD-57F6EB31C620"><gtr:id>E594C221-4738-4152-9CFD-57F6EB31C620</gtr:id><gtr:name>Fraunhofer Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F505561F-C42A-4559-96A1-DB13B5B06324"><gtr:id>F505561F-C42A-4559-96A1-DB13B5B06324</gtr:id><gtr:name>Telethon Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82885B82-50BA-40DE-B7A7-62CAF220EC58"><gtr:id>82885B82-50BA-40DE-B7A7-62CAF220EC58</gtr:id><gtr:name>General Secretariat For Research &amp; Technology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/00866200-F62B-429B-BF02-A0A841684ED5"><gtr:id>00866200-F62B-429B-BF02-A0A841684ED5</gtr:id><gtr:name>University of Salamanca</gtr:name><gtr:address><gtr:line1>Universidad de Salamanca</gtr:line1><gtr:line2>Patio de Escuelas 1</gtr:line2><gtr:line4>Salamanca</gtr:line4><gtr:line5>37071</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D3CC600D-1AD4-4272-99C1-158BDF55308C"><gtr:id>D3CC600D-1AD4-4272-99C1-158BDF55308C</gtr:id><gtr:name>Alliance Against Cancer</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3F817F1C-4D4C-4325-A83C-601A871E5487"><gtr:id>3F817F1C-4D4C-4325-A83C-601A871E5487</gtr:id><gtr:name>ORION Pharma</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6928AD0A-07BA-4B4C-8077-EDC03D56B3B8"><gtr:id>6928AD0A-07BA-4B4C-8077-EDC03D56B3B8</gtr:id><gtr:name>Netherlands Organisation for Health Research and Development</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3D2D81D-2671-410B-9D1C-BBBBDA8CF466"><gtr:id>E3D2D81D-2671-410B-9D1C-BBBBDA8CF466</gtr:id><gtr:name>Johnson &amp; Johnson Ltd</gtr:name><gtr:address><gtr:line1>Foundation Park</gtr:line1><gtr:line2>Roxborough Way</gtr:line2><gtr:line4>Maidenhead</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>SLG 3UG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1CC23DC2-3991-4123-B5F2-83C1F5793403"><gtr:id>1CC23DC2-3991-4123-B5F2-83C1F5793403</gtr:id><gtr:name>F. Hoffmann-La Roche AG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ADD77807-7B00-4A41-A7A4-09A5D0BB801C"><gtr:id>ADD77807-7B00-4A41-A7A4-09A5D0BB801C</gtr:id><gtr:name>Esteve</gtr:name><gtr:address><gtr:line1>Avda. Mare de Deu de Montserrat, 221</gtr:line1><gtr:postCode>E-08041</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E777F7E-8B7E-406A-87FB-39A7026F891F"><gtr:id>4E777F7E-8B7E-406A-87FB-39A7026F891F</gtr:id><gtr:name>Uppsala University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/712757B9-CD96-4383-A0F9-F0D7F1B4951C"><gtr:id>712757B9-CD96-4383-A0F9-F0D7F1B4951C</gtr:id><gtr:name>Vitro (Biobanking services)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/98C379BE-5412-4C64-9838-F46315C76505"><gtr:id>98C379BE-5412-4C64-9838-F46315C76505</gtr:id><gtr:name>Health Research Board (HRB)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6A5D0F02-E386-44C0-BBAE-17AAC62AF2BA"><gtr:id>6A5D0F02-E386-44C0-BBAE-17AAC62AF2BA</gtr:id><gtr:name>Netherlands Federation of University Medical Centres (NFU)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E65D5505-6DF9-4801-9019-B9EDE5D0EE5D"><gtr:id>E65D5505-6DF9-4801-9019-B9EDE5D0EE5D</gtr:id><gtr:name>University Medical Center Gronigen</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6C747631-6855-48CC-BF64-0316AABB5DF8"><gtr:id>6C747631-6855-48CC-BF64-0316AABB5DF8</gtr:id><gtr:name>University of Malta</gtr:name><gtr:address><gtr:line1>Administration Bldg</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/61D20CC7-787C-455B-936A-3E16D0122205"><gtr:id>61D20CC7-787C-455B-936A-3E16D0122205</gtr:id><gtr:name>Semmelweis University</gtr:name><gtr:address><gtr:line1>Semmelweis University</gtr:line1><gtr:line2>Alkotas u. 44</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/620DB27D-4014-4278-AAD1-11105CC6BDEA"><gtr:id>620DB27D-4014-4278-AAD1-11105CC6BDEA</gtr:id><gtr:name>Novo Nordisk</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5A8C32C1-29FC-4B3A-8C07-C792DC7AF31B"><gtr:id>5A8C32C1-29FC-4B3A-8C07-C792DC7AF31B</gtr:id><gtr:name>Legal Pathways Institute for Health and Bio-Law</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5F32098B-3CD7-41E1-BD83-220F3383C071"><gtr:id>5F32098B-3CD7-41E1-BD83-220F3383C071</gtr:id><gtr:name>Spanish Ministry of Science and Innovation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A2EE26A2-8275-447D-9B11-61E0674537F5"><gtr:id>A2EE26A2-8275-447D-9B11-61E0674537F5</gtr:id><gtr:firstName>William</gtr:firstName><gtr:otherNames>Osmond</gtr:otherNames><gtr:surname>Cookson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/31306DBD-0EEB-4684-9CA0-B35B5C0B52F1"><gtr:id>31306DBD-0EEB-4684-9CA0-B35B5C0B52F1</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Owen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9C559096-8F19-465C-87D0-1DBFFA282F5F"><gtr:id>9C559096-8F19-465C-87D0-1DBFFA282F5F</gtr:id><gtr:firstName>Judith</gtr:firstName><gtr:otherNames>Anne</gtr:otherNames><gtr:surname>Goodship</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9FAD231C-DA2D-4CBD-A1F3-BF11E5203F4E"><gtr:id>9FAD231C-DA2D-4CBD-A1F3-BF11E5203F4E</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>McGuffin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8ABECAD9-8B53-4898-91DD-B5C5A1A0459B"><gtr:id>8ABECAD9-8B53-4898-91DD-B5C5A1A0459B</gtr:id><gtr:firstName>Carl</gtr:firstName><gtr:surname>Clarke</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0486B5FC-45CA-442A-A0F9-215D29A01AB4"><gtr:id>0486B5FC-45CA-442A-A0F9-215D29A01AB4</gtr:id><gtr:firstName>Karen Elaine</gtr:firstName><gtr:surname>Morrison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BE2F9B1E-AFE2-4470-8947-A37BAA446C40"><gtr:id>BE2F9B1E-AFE2-4470-8947-A37BAA446C40</gtr:id><gtr:firstName>Miriam</gtr:firstName><gtr:otherNames>Fleur</gtr:otherNames><gtr:surname>Moffatt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A81109F6-7B27-4E09-A5ED-DE8FCEA82F38"><gtr:id>A81109F6-7B27-4E09-A5ED-DE8FCEA82F38</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:otherNames>Graham</gtr:otherNames><gtr:surname>Dunlop</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9B069BD-5D15-43B4-B0D6-6A64211DC850"><gtr:id>C9B069BD-5D15-43B4-B0D6-6A64211DC850</gtr:id><gtr:firstName>Ellen</gtr:firstName><gtr:surname>Solomon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4BD46A99-6CCE-45C4-A615-3C8DBE0AC41D"><gtr:id>4BD46A99-6CCE-45C4-A615-3C8DBE0AC41D</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Rees</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D5931BD0-9118-40A8-83E7-F0BDAB9FF707"><gtr:id>D5931BD0-9118-40A8-83E7-F0BDAB9FF707</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:otherNames>Alexander</gtr:otherNames><gtr:surname>Yuille</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/43021168-77AE-40B4-862F-AB4797FCA87F"><gtr:id>43021168-77AE-40B4-862F-AB4797FCA87F</gtr:id><gtr:firstName>Harry</gtr:firstName><gtr:surname>Campbell</gtr:surname><gtr:orcidId>0000-0002-6169-6262</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A64B614B-387F-4A87-8F08-18C3C2916676"><gtr:id>A64B614B-387F-4A87-8F08-18C3C2916676</gtr:id><gtr:firstName>Julie</gtr:firstName><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5424B5E5-25D2-4542-94FD-959A58B8EE69"><gtr:id>5424B5E5-25D2-4542-94FD-959A58B8EE69</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>Royston</gtr:otherNames><gtr:surname>Webster</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/63454C57-257F-4FAE-8D1D-410381F0B810"><gtr:id>63454C57-257F-4FAE-8D1D-410381F0B810</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Hattersley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BB440D9D-19FD-47E8-9F9D-5D0F7899E02B"><gtr:id>BB440D9D-19FD-47E8-9F9D-5D0F7899E02B</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Lewis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0BAAB362-6169-494D-B44C-9A9A56971C78"><gtr:id>0BAAB362-6169-494D-B44C-9A9A56971C78</gtr:id><gtr:firstName>Shomi</gtr:firstName><gtr:surname>Bhattacharya</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/383EE2D6-5E49-4064-AE3A-95B17D7CA76D"><gtr:id>383EE2D6-5E49-4064-AE3A-95B17D7CA76D</gtr:id><gtr:firstName>Patricia</gtr:firstName><gtr:surname>Munroe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/38125C45-5239-4F7C-A939-4140F109A5F2"><gtr:id>38125C45-5239-4F7C-A939-4140F109A5F2</gtr:id><gtr:firstName>Alistair</gtr:firstName><gtr:otherNames>Scott</gtr:otherNames><gtr:surname>Hall</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2165B74E-9235-4B68-B481-EAB07E3083A9"><gtr:id>2165B74E-9235-4B68-B481-EAB07E3083A9</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Caulfield</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EB134AF9-197A-4970-8C8E-6D9132EBEB02"><gtr:id>EB134AF9-197A-4970-8C8E-6D9132EBEB02</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Ian</gtr:otherNames><gtr:surname>McCarthy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/801F3019-88AB-4A46-98EB-E90FBC781DBE"><gtr:id>801F3019-88AB-4A46-98EB-E90FBC781DBE</gtr:id><gtr:firstName>Nilesh</gtr:firstName><gtr:otherNames>Jayantilal</gtr:otherNames><gtr:surname>Samani</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/147A4A54-6D76-463F-99BD-C21F5AB451A4"><gtr:id>147A4A54-6D76-463F-99BD-C21F5AB451A4</gtr:id><gtr:firstName>Alastair</gtr:firstName><gtr:surname>Compston</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4298678A-F46A-4F04-8148-6ED71C2A9150"><gtr:id>4298678A-F46A-4F04-8148-6ED71C2A9150</gtr:id><gtr:firstName>William</gtr:firstName><gtr:surname>Ollier</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600237"><gtr:id>F6907B23-7016-49D8-8F58-38ADC0E2FC6C</gtr:id><gtr:title>The UK DNA Banking Network</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600237</gtr:grantReference><gtr:abstractText>The UK DNA Banking Network (UDBN at www.dna-network.ac.uk) manages data and sample collections for common human diseases. High quality management is essential for genetic epidemiology. It saves time and money; allows UK scientists access to these valuable resources; and allows the gathering together of the large series that are now essential to find genes underlying common diseases. Already six of the collections have been used in this way with &amp;gt;6 billion genetic variants tested in &amp;gt;12,000 samples. Round the world, genetic epidemiologists are trying to tackle the huge logistic problems associated with these numbers. UDBN has solved most of them. No other nation has yet got this sort of infrastructure. We now plan to speed up the process of making collections for more diseases so that more genes will be found quicker and cheaper. We want to see UDBN serve the needs of all collectors - not only those funded by MRC. We also want to ensure that the management we provide remains at the cutting edge of robotics and informatics. Our current collections are in Coronary Artery Disease; Colorectal cancer; Glomerulonephritis; Parkinson?s Disease; Asthma; Eczema; Type 2 Diabetes; Breast Cancer; Hypertension; Multiple Sclerosis; Alzheimer?s Disease; Macular Degeneration; Unipolar Depression.</gtr:abstractText><gtr:technicalSummary>A national community resource has been created for DNA sample and data management to support UK scientists investigating genetic risk factors in 13 high impact diseases. The resource - the UK DNA Banking Network - comprises ISO 2001 facilities in CIGMR (Manchester) and ECACC (Salisbury) for managing DNA and cell samples respectively. The facilities make extensive use of robotics supported by LIMS. The Network has a highly functional website that provides a ?Collaboration Service? akin to a dating agency for collaboration. This service involves linking of CIGMR and ECACC LIMS with collectors? phenotype databases. UDBN collections are being analysed in high density genome wide association and other studies. This community resource is the most advanced of its kind.

UDBN seeks renewed support to retain this world-leading position. Support will allow us to promote wider use of the samples; to sustain the Network; to maintain its infrastructure; to complete the data management infrastructure; to roll out the management capabilities for other human disease collections (including clinical trials); massively to save costs to all funding bodies planning to support new collections; to adapt UDBN?s organisation as links to other funders grow; to test revenue streams for UDBN that will ensure cost-effective use of resources and to implement a programme of research and development. This programme will achieve wider harmonisation of DNA sample management processes; will conserve irreplaceable genomic DNA samples; will facilitate DNA sample accrual from rarer diseases or sub-types (from wax blocks); and will facilitate accrual of further sub-cellular fractions (RNA) for high throughput analysis.</gtr:technicalSummary><gtr:fund><gtr:end>2010-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>825352</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Economics and Political Science (University of London)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>FD1B29D2-C74B-44F4-9F83-B1034A3BAF87</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-41</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>ORION Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>B501C286-F52F-4469-9559-0E699CE41C0C</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-23</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>F. Hoffmann-La Roche AG</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>44264733-8948-4A68-A8A3-9F81411A753E</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-16</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Klagenfurt (Alpen-Adria-Universit?t Klagenfurt)</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>F13705AF-E68D-4F25-A3F7-2CB8EC759EE0</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-47</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Helmholtz Centre for Infection Research (HZI)</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>4E6C2D11-3FB2-4F32-A0FF-5BF933781FB9</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-7</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Aventis</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>93A9AF14-5378-48E0-AEB5-3EE11BFC93BF</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-20</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Autonomous University of Madrid (UAM)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>90EB70EC-9330-4F33-B476-CA9981EAD9A6</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-42</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Telethon Foundation</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>6769B5AF-7CB2-42CE-836F-1225A8A3C252</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-13</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novo Nordisk</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>0F511906-BDB2-44F9-BB20-736F36BDC5A6</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-19</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Helmholtz Zentrum Munchen</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>3D9AF52D-9ECF-48BC-BD80-53638838AC10</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-3</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Malta</gtr:collaboratingOrganisation><gtr:country>Malta, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>78706270-2DF1-47A3-92B9-970D6C466CA8</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-8</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Cancer Research, Genoa (IST) (Istituto Nazionale per la Ricerca sul Cancro di Genova)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>647F0E55-6AA3-41D6-93F3-A15D16E1542C</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-24</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Agency for Research on Cancer (IARC)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>D4825E5A-CE9F-4390-90C5-A7C64F0684B2</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-6</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Molecular Medicine Ireland</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>Irish Clinical Research Infrastructure Network (ICRIN)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>E7F4C9C2-93B6-464E-97C3-E3860F9C89A5</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-15</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Alliance Against Cancer</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>90F81E7A-BAD1-4FA4-9BB1-B41D6D135FB7</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-40</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Netherlands Organisation for Health Research and Development</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>849A7522-F2F1-48D5-842A-0E3735DE547E</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-33</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academy of Athens</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Biomedical Research Foundation Academy of Athens</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>337B09B0-0E35-437E-9888-166569AC5F8F</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-46</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>B7F0C62C-6BEB-40B4-AD6C-D7FBC9DCB4A3</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-1</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Research Council</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>ITB CNR Institute for Biomedical Technologies</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>E8824D91-DCE1-4FFC-BC2E-FAFBBA7D72D1</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-25</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>deCODE genetics</gtr:collaboratingOrganisation><gtr:country>Iceland, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>571508E8-F36B-41BA-A74C-EA1788D00952</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-38</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Uppsala University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>5B99F130-43BF-4319-B14C-C78BB94102EA</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-4</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bayer</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>61F3A67A-89E6-44E5-9ADC-0A2878E5BBD9</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-14</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>6A65E3DD-3E55-4B95-96E7-B946D01F5C45</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-17</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>E3A95378-AED6-4BCE-AA02-C59D98CD2B29</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-6</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Medical Center Gronigen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>F3C1123D-9FB3-48AF-A4F1-2EC6105D4568</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-31</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Fraunhofer Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>The Fraunhofer Institute for Biomedical Engineering (IBMT)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>D76EF414-5CBC-457F-8B35-F446267B1458</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-34</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Helmholtz Zentrum Munchen</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>25C289AA-3F73-4CFC-B55C-F751677662AD</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-10</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Graz</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>A16E6BB6-284D-4906-B102-589185CFBE12</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-1</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Netherlands Federation of University Medical Centres (NFU)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>6A2B660A-6909-452C-AA0F-4C065B08FACD</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-32</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johnson &amp; Johnson</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>A86F3B6D-FD56-4A1D-911E-F403B27AA0B0</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-22</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Norwegian Institute of Public Health</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>98208B50-5A75-498E-AB9F-F18ACB542F3F</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-22</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UK Biobank</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>08E3DBE7-4784-4A0B-9D93-9555DA7B44B5</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-28</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Graz</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>A2C1F19E-11C4-45F9-B908-750C267A16FE</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-8</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Health Research Board (HRB)</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>55BCF969-DBF9-429E-8713-6AA1A3281314</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-26</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Bioscience Technologies</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>B8E04E0C-D6C8-43C8-B499-DA8817AC6419</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-44</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College Hospital NHS Foundation Trust (NCH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Acropolis</gtr:description><gtr:id>08C2FC4F-7807-409B-9B9E-1DEE0B75A57B</gtr:id><gtr:impact>Too soon</gtr:impact><gtr:outcomeId>s8RX3AL49is-1</gtr:outcomeId><gtr:piContribution>Management of data integration project for research between MAHSC and KHP</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCB Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>4E9BFE17-E190-4CFE-9009-23F366D9ED37</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-18</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute for Molecular Cell Biology and Genetics</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>D4F5F004-5F02-48E1-A8C0-487000AB1D38</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-18</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>993AAEEB-15C1-4953-980D-04B5743B76B7</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-15</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Legal Pathways Institute for Health and Bio-Law</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>F124A1CA-254D-4DD8-8C45-50E705BC1B5C</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-37</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Almirall</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>8C9DC6FD-DE39-4E99-A135-572EBA1CEC53</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-24</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Genzyme Corporation</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>43D99B77-2544-4B6B-87B8-3D65F3D02725</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-12</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>77E778F0-0B98-4344-8E65-766FFA9DF1CF</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-11</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Vitro (Biobanking services)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>E559D270-5F75-42AC-8AD7-FD7BA55ACF34</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-20</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>German Federal Ministry of Education and Research</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>D35A68F0-4FC5-47CF-8B4D-4219C1D4FBDF</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-35</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>62F30A54-7A2E-4963-BA21-0174C06516BA</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-21</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Salamanca</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>D8BB26EF-FE18-4FC1-801E-0D7A51451CFA</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-12</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lundbeck Foundation</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>A92C1349-7263-4CD7-952F-44CE11CF8651</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-25</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>7BC5B439-17EF-4532-A664-302F041F3CA4</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-27</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boehringer Ingelheim</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>D3BCC267-7F85-40E4-8C1B-4B7BA1F4D5F9</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-21</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of the Netherlands</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Ministry of Education, Culture and Science Netherlands</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>C686E3AB-00AB-4D0D-B843-CFE047429FD4</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-29</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>B5A17DD8-C8D8-4341-B587-52AE194A2DBB</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-23</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Icelandic Centre for Research (RANN?S)</gtr:collaboratingOrganisation><gtr:country>Iceland, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>1BC27101-1CD5-4A74-8020-571CBCD4A7D1</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-30</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>F25B691A-93AF-4B5B-9F67-F576391C38F0</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-13</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Semmelweiss University</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>EC0FF04B-FA13-4741-9E67-0A63C020EB5F</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-10</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Stratum</gtr:description><gtr:id>AE8CE13A-CE24-4E5E-98FB-2FB07D70B8B0</gtr:id><gtr:impact>Too soon</gtr:impact><gtr:outcomeId>mEpdbs3ZrRS-1</gtr:outcomeId><gtr:piContribution>Financial modelling for national biobanking solutions</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Esteve</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>7FCC6A3C-1841-40D6-B37D-70D09BF962C4</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-26</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>4F148C74-1227-45B6-BFEC-871F3E4F2C63</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-9</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Norwegian University of Science and Technology (NTNU)</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>907C8C10-07AD-4FA3-9DE7-E3505C0DDC1D</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-9</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>CC508485-403A-42CE-8E27-805123DF30C9</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-5</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Respiratory Medicine</gtr:department><gtr:description>IMI U-biopred</gtr:description><gtr:id>5C809A4D-4B7C-4241-B1F2-1B108D294C52</gtr:id><gtr:impact>Too soon</gtr:impact><gtr:outcomeId>JANpCNAekpN-1</gtr:outcomeId><gtr:piContribution>Biobanking infrastructure</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska University Hospital</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>8C8E1D3B-C98C-40AB-B6DA-09172939E0BC</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-4</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>1383BEC8-02CF-4BA7-A6DC-D1744A68BC8B</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-16</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>725F93E3-0F33-4FC1-A98A-867FC51ECCCB</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-2</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of France</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>F?d?ration Hospitali?re de France (FHF)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>0D923D57-0921-4BA1-BD2A-608560F47192</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-14</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Federal Ministry of Science, Research and Economy (BMWFW)</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>4A0B58DD-52C3-4B7F-9585-A33DFA4F7B97</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-36</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>General Secretariat For Research &amp; Technology</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>C67494C8-FD73-4446-83B7-FCAD053B8192</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-45</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>F810E9D2-78DA-4D97-9E77-297CB6F83FEC</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-5</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Spanish Ministry of Science and Innovation</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Institute of Health &quot;Carlos III&quot; (ISCIII)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>561C6D88-B481-4766-8892-1D02767AF844</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-19</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Division of Metabolic Diseases</gtr:department><gtr:description>IMI EMTRAIN</gtr:description><gtr:id>E648DE7C-10AF-401E-A92A-5C527A04CE3E</gtr:id><gtr:impact>www.emtrain.eu</gtr:impact><gtr:outcomeId>soAZBr4KsPv-3</gtr:outcomeId><gtr:partnerContribution>Initiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobankingInitiating promotion of education and training for biobanking</gtr:partnerContribution><gtr:piContribution>Constructing catalogue of medicines research tertiary education courses in EU and Associated States. Identification of gaps in provision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tartu</gtr:collaboratingOrganisation><gtr:country>Estonia, Republic of</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>B4D33FD1-1196-4D48-AD30-825869264C8C</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-11</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Italian National Health Service</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Istituto Superiore di Sanit? (ISS)</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>A22E19EC-1633-4756-A6AE-4AF3D0149717</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-17</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of Estonia</gtr:collaboratingOrganisation><gtr:country>Estonia, Republic of</gtr:country><gtr:department>Ministry of Education and Research Estonia</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>E64FD76C-A586-4DD8-8E85-AA70E3D2E1C7</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-43</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Life Science Governance Institute, Vienna</gtr:department><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>7E8A9DC4-FA6B-4B36-8F8A-E0EEC46A6CC4</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-39</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Biobanking and BioMolecular Resources Infrastructure</gtr:description><gtr:id>FA4F4A00-893E-4AE8-A6C7-482C9AD49619</gtr:id><gtr:impact>Three EU Member States have agreed in principle to constitute the initial members of the European Research Infrastructure Consortium for biobanking and biomolecular resources. The concept is on the RCUK Large Facilities Roadmap.</gtr:impact><gtr:outcomeId>80E4932B2A6-7</gtr:outcomeId><gtr:partnerContribution>Strategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNIrish Clinical Research Infrastructure NetworkStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBNStrategy development for UDBN</gtr:partnerContribution><gtr:piContribution>I am Associate Coordinator for the BBMRI Preparatory Phase responsible for development of the operational plan. This attracted ?150,000 from FP7-Research Infrastructures.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>UDBN website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>7EB844BB-C3AE-4D06-8A5A-03716BD34ACA</gtr:id><gtr:impact>Website with open access and access restricted to registered users deemed to be bona fide researchers by UDBN. Restricted access permits search of phenotype data with results in summary form only.

UDBN has distributed 80,000 DNA samples for numerous studies in part through use of the website.</gtr:impact><gtr:outcomeId>320C20EF275</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Manchester Academic Health Science Centre</gtr:department><gtr:description>Manchester Academic Health Science Centre Pilot Funding/University of Manchester</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>University of Manchester</gtr:fundingOrg><gtr:id>7A634841-AD35-4FFC-B4DE-96CBD073216E</gtr:id><gtr:outcomeId>8A01A380ECC0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7-INFRASTRUCTURES-2007-1</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>7372AFA4-7EA9-4939-8EC4-401C5AF4E88F</gtr:id><gtr:outcomeId>B469CE13AC70</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovative Medicines Initiative (IMI) Call 1 Topic 14</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>945D124A-7711-49CA-ACAC-B55086DC6E19</gtr:id><gtr:outcomeId>5684FD0DF510</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GeneLibrary Ireland</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>468E3E40-0C23-4B8B-AAF0-8974929E3124</gtr:id><gtr:impact>None</gtr:impact><gtr:outcomeId>BEDF5F77F3B</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Confederation of Cancer Biobanking</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>AD8C9B26-1219-49DD-90D2-9508121AE7EC</gtr:id><gtr:impact>no</gtr:impact><gtr:outcomeId>09221BA4755</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Permits centralised web-based project management of collection activities (track sample; track consent; phenotype data entry).</gtr:description><gtr:id>F9EFA26B-36C7-4C9B-816C-F163CF31927B</gtr:id><gtr:impact>Too early to say</gtr:impact><gtr:outcomeId>772A094B1A2</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PRELIMS</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This Collaboration Management System permits the initiation of collaborations between resource owners in UDBN and third parties.</gtr:description><gtr:id>869640C0-D1A8-455E-A072-A1E8243460D1</gtr:id><gtr:impact>UDBN has distributed 80,000 aliquots to researchers involved in different collaborative arrangements.</gtr:impact><gtr:outcomeId>DD774642402</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CoMS</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0744743F-C19E-446B-9486-951725716238</gtr:id><gtr:title>Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/600db8064142f4f54a9f5577f16bc9ec"><gtr:id>600db8064142f4f54a9f5577f16bc9ec</gtr:id><gtr:otherNames>Rodriguez-Fontenla C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2326-5191</gtr:issn><gtr:outcomeId>56e05979107e47.24419212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAAE68EB-58F2-4121-BDCD-AFD71DA962FA</gtr:id><gtr:title>Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>5a9d52036c66e0.31731063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DDE50D8-C28A-4716-830A-A0CFA579C4A4</gtr:id><gtr:title>Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e2a3e6a01ae8c15f79ea1314f448102"><gtr:id>4e2a3e6a01ae8c15f79ea1314f448102</gtr:id><gtr:otherNames>Joshi PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5aaa64e5d09907.60419450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28896C32-6102-4883-946B-770DB9A67769</gtr:id><gtr:title>The non-synonymous SNP, R1150W, in SCN9A is not associated with chronic widespread pain susceptibility.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/132f9c9c536df1454ed81c26461d0e2a"><gtr:id>132f9c9c536df1454ed81c26461d0e2a</gtr:id><gtr:otherNames>Holliday KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>pm_16670_20_23006801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA0A7F9E-BDA1-4E5F-9EB4-69C98E5B3AEF</gtr:id><gtr:title>IGF2 gene polymorphisms and IGF-II concentration are determinants of longitudinal weight trends in type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d05ed7e7460c5eb6d8f4e29c13afff73"><gtr:id>d05ed7e7460c5eb6d8f4e29c13afff73</gtr:id><gtr:otherNames>Narayanan RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0947-7349</gtr:issn><gtr:outcomeId>56e059db3e1306.70630392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5815B81E-05E6-40ED-B056-F27CB3D62E2F</gtr:id><gtr:title>Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.</gtr:title><gtr:parentPublicationTitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d650d10593bac5fd741f0c8a365fc160"><gtr:id>d650d10593bac5fd741f0c8a365fc160</gtr:id><gtr:otherNames>Rothwell S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2326-5191</gtr:issn><gtr:outcomeId>5aaa64e78c4716.71083868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F487951E-EA3D-4A3C-B4E9-793DE259E260</gtr:id><gtr:title>Erratum: Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd0cb81ce139aaca26922279199f2d6a"><gtr:id>dd0cb81ce139aaca26922279199f2d6a</gtr:id><gtr:otherNames>Sniekers S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5aaa64e72d6972.17710839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A604523-E1DF-4197-835D-D92141864A18</gtr:id><gtr:title>2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/609f27a6069c218e75d993a26a7249b1"><gtr:id>609f27a6069c218e75d993a26a7249b1</gtr:id><gtr:otherNames>Mancia G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>pm_13563_23_23771844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12EB6287-DD92-4395-951A-1C8C9DDF3740</gtr:id><gtr:title>Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fc4eefd621187bd6531525a0d279e47"><gtr:id>4fc4eefd621187bd6531525a0d279e47</gtr:id><gtr:otherNames>Surendran P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b814b423b364.28658523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57976C59-D532-4E58-AAED-0455FBB9AD00</gtr:id><gtr:title>Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/614a404b39aa1ba1001979e9cd3ea2e4"><gtr:id>614a404b39aa1ba1001979e9cd3ea2e4</gtr:id><gtr:otherNames>Styrkarsdottir U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5aaa64e928be81.98678254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2228D705-4FB3-4EDE-B033-F31A9E4CB27F</gtr:id><gtr:title>Observational study on variability between biobanks in the estimation of DNA concentration.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99186fe36784093a89ae67dc4a70fcb"><gtr:id>d99186fe36784093a89ae67dc4a70fcb</gtr:id><gtr:otherNames>Brown J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>C614B623DF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4E9ECE4-8FF7-4A7A-B3A0-BC8649476EF9</gtr:id><gtr:title>Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14bd64c16502c520af788739a29cb702"><gtr:id>14bd64c16502c520af788739a29cb702</gtr:id><gtr:otherNames>Lilleker JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>5aaa64e48caae5.15040860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C13A6C9-5B1C-4F42-9D45-8857A8FD1580</gtr:id><gtr:title>Genetic association study of NF-?B genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe41a7ffa856ed36e739a0a32de3913"><gtr:id>fbe41a7ffa856ed36e739a0a32de3913</gtr:id><gtr:otherNames>Chinoy H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>pm_16670_20_22210660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4258943-236C-4B95-9AAE-F086505C0FB3</gtr:id><gtr:title>Discovery of novel heart rate-associated loci using the Exome Chip.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/635664d7d143491072cf15526248ff34"><gtr:id>635664d7d143491072cf15526248ff34</gtr:id><gtr:otherNames>van den Berg ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a9d5205132934.26884516</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>500A7082-E10E-48DC-9685-7573D640B99E</gtr:id><gtr:title>Genetic basis of cranial cruciate ligament rupture (CCLR) in dogs.</gtr:title><gtr:parentPublicationTitle>Connective tissue research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10fe29bc65d5fcb8f335c43b0c42c07d"><gtr:id>10fe29bc65d5fcb8f335c43b0c42c07d</gtr:id><gtr:otherNames>Baird AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-8207</gtr:issn><gtr:outcomeId>56e05e95658bf1.33554996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93C98E38-88B1-4DC6-B783-BC993A93B137</gtr:id><gtr:title>Genetic variation in inflammatory and bone turnover pathways and risk of osteolytic responses to prosthetic materials.</gtr:title><gtr:parentPublicationTitle>Journal of orthopaedic research : official publication of the Orthopaedic Research Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bee2df33fa28236c7bb927524e6facea"><gtr:id>bee2df33fa28236c7bb927524e6facea</gtr:id><gtr:otherNames>MacInnes SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0736-0266</gtr:issn><gtr:outcomeId>56e05893c53f64.05634939</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2EA6452-416C-4F29-8863-D9FBEEFE51AD</gtr:id><gtr:title>Toward a roadmap in global biobanking for health.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f27012046ca2dce5e73be005706375fb"><gtr:id>f27012046ca2dce5e73be005706375fb</gtr:id><gtr:otherNames>Harris JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>pm_16670_20_22713808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA710AFB-A7B1-49B4-A185-DF3BDE953A42</gtr:id><gtr:title>The UK DNA banking network: a &amp;quot;fair access&amp;quot; biobank.</gtr:title><gtr:parentPublicationTitle>Cell and tissue banking</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdc4dcc726a87babd2e7d3f602462e8c"><gtr:id>bdc4dcc726a87babd2e7d3f602462e8c</gtr:id><gtr:otherNames>Yuille M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1389-9333</gtr:issn><gtr:outcomeId>B0C62830BC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D76904E-5725-459B-AAE4-21D3CB60E46B</gtr:id><gtr:title>Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated?</gtr:title><gtr:parentPublicationTitle>Journal of cardiac failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8a4c1df097b481b80274a70709147e9"><gtr:id>a8a4c1df097b481b80274a70709147e9</gtr:id><gtr:otherNames>Mamas MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-9164</gtr:issn><gtr:outcomeId>Vawc5FYuj6d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF0D2D26-B4D6-46FE-B78F-6B35DB56EDCE</gtr:id><gtr:title>Heightened autoantibody immune response to citrullinated calreticulin in bronchiectasis: Implications for rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edcac39fe38e2117f735d252ba3820e9"><gtr:id>edcac39fe38e2117f735d252ba3820e9</gtr:id><gtr:otherNames>Clarke A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5aaa64e692ef64.78143877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B595C9C-EC7E-46D9-A2AF-8A4F09395DFA</gtr:id><gtr:title>Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40d4aefc449834f9c0aba834ea778607"><gtr:id>40d4aefc449834f9c0aba834ea778607</gtr:id><gtr:otherNames>Mitchell AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e05d21179be7.96312838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5378B131-F73A-4BC8-8E05-55626F693CD2</gtr:id><gtr:title>Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/643b1b617e1aee683833a188215b7d78"><gtr:id>643b1b617e1aee683833a188215b7d78</gtr:id><gtr:otherNames>Ghosh SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>pm_13563_23_23589565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABC53F3E-BC31-4F02-BDCC-FBE1515AE807</gtr:id><gtr:title>GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/debdd1847f0951b6d938144539fafa6f"><gtr:id>debdd1847f0951b6d938144539fafa6f</gtr:id><gtr:otherNames>Trampush JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>5aaa64e58ba441.36839956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C357AE7-C316-402E-9263-79E5F8B9FAB0</gtr:id><gtr:title>ADAMTS7 cleavage and vascular smooth muscle cell migration is affected by a coronary-artery-disease-associated variant.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe74d2d69d2455ab01cab4633ffc29ce"><gtr:id>fe74d2d69d2455ab01cab4633ffc29ce</gtr:id><gtr:otherNames>Pu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_13563_23_23415669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB29E09D-C645-4770-8CC3-F8791BAF1DD6</gtr:id><gtr:title>Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a75de1aab984e81fe84315099b512f1"><gtr:id>0a75de1aab984e81fe84315099b512f1</gtr:id><gtr:otherNames>Turcot V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a9d5200673b49.10048539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11D7B9F2-B08D-48B7-AFD3-28B5082204B2</gtr:id><gtr:title>Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd0cb81ce139aaca26922279199f2d6a"><gtr:id>dd0cb81ce139aaca26922279199f2d6a</gtr:id><gtr:otherNames>Sniekers S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5aaa64e6d317e1.02115497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF05AFC2-08AF-42F5-AD06-5B535D997B6B</gtr:id><gtr:title>A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/110682094a421646bda298b3e8358061"><gtr:id>110682094a421646bda298b3e8358061</gtr:id><gtr:otherNames>Davies G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_16670_20_23207651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBE975E0-0690-4513-BFE7-9955A4B210A3</gtr:id><gtr:title>Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a06bcb25009e3fface332b51a9c2bf7b"><gtr:id>a06bcb25009e3fface332b51a9c2bf7b</gtr:id><gtr:otherNames>Shah T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13563_23_23977022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4FBF8B1-2288-4151-92A9-628A88A65483</gtr:id><gtr:title>Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37de4479f1759b4f36885d27564d5018"><gtr:id>37de4479f1759b4f36885d27564d5018</gtr:id><gtr:otherNames>K?ttgen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13563_23_23263486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80F9921E-E20B-4BD2-B3F4-19C80CE65B78</gtr:id><gtr:title>GWAS-based pathway analysis differentiates between fluid and crystallized intelligence.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e4b7f05659cdfeb927023e9589acc8a"><gtr:id>8e4b7f05659cdfeb927023e9589acc8a</gtr:id><gtr:otherNames>Christoforou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>56e058e2982812.03245504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA5E0EA6-66A7-4FE3-AA30-0055F46C75AF</gtr:id><gtr:title>Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adb3aef1c2829f37d3d6bd9a73c49745"><gtr:id>adb3aef1c2829f37d3d6bd9a73c49745</gtr:id><gtr:otherNames>Miller FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>56e059aa78f748.34039487</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC8933A0-7059-4482-BE25-C12813490D3F</gtr:id><gtr:title>The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f460767649781454eba53de21a508d00"><gtr:id>f460767649781454eba53de21a508d00</gtr:id><gtr:otherNames>Ehret GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b814b3e8a928.87467444</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D355D79-CA57-426B-A9DE-DEF46DA4D1CC</gtr:id><gtr:title>Common SNPs explain some of the variation in the personality dimensions of neuroticism and extraversion.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1b5f9718fe2eabc4269ae6e77f626f5"><gtr:id>c1b5f9718fe2eabc4269ae6e77f626f5</gtr:id><gtr:otherNames>Vinkhuyzen AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>pm_16670_20_22832902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E50E59D-10BA-4E98-A857-24FD07F7C605</gtr:id><gtr:title>Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking.</gtr:title><gtr:parentPublicationTitle>Biopreservation and biobanking</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58ae016a4386b51a67493edfa71ea497"><gtr:id>58ae016a4386b51a67493edfa71ea497</gtr:id><gtr:otherNames>Doucet M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1947-5543</gtr:issn><gtr:outcomeId>5aaa64e83e54a2.41397588</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CD2A975-E2F4-43BA-937C-8041641780A5</gtr:id><gtr:title>A blood pressure-associated variant of the SLC39A8 gene influences cellular cadmium accumulation and toxicity.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55ccc78aeedcc3165e7329451a088c1c"><gtr:id>55ccc78aeedcc3165e7329451a088c1c</gtr:id><gtr:otherNames>Zhang R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58b814b33398c5.16337754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2265803E-86D6-4EAF-9442-A50E069E43A4</gtr:id><gtr:title>Loci influencing blood pressure identified using a cardiovascular gene-centric array.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2c3233fe4bf0a3e0f9dddb16e1aa7fa"><gtr:id>a2c3233fe4bf0a3e0f9dddb16e1aa7fa</gtr:id><gtr:otherNames>Ganesh SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13563_23_23303523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89A02943-0B92-4E6E-9D64-C70770FBCCA7</gtr:id><gtr:title>A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol lowering.</gtr:title><gtr:parentPublicationTitle>Pharmacogenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5d1f0ca8ca1ec9664a9c61bebc2d80f"><gtr:id>a5d1f0ca8ca1ec9664a9c61bebc2d80f</gtr:id><gtr:otherNames>Leusink M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1462-2416</gtr:issn><gtr:outcomeId>58b814b4aa6119.24130776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C14E309B-F54F-440A-AA1C-53271CC57610</gtr:id><gtr:title>Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf8d5efc3393ef9a13e625223ce098ec"><gtr:id>bf8d5efc3393ef9a13e625223ce098ec</gtr:id><gtr:otherNames>MacDonald TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn><gtr:outcomeId>5a9d5201a6e991.45268870</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF46017E-0A7D-4E8A-9116-B5C2A18497B2</gtr:id><gtr:title>Evaluation of the genetic overlap between osteoarthritis with body mass index and height using genome-wide association scan data.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88ac149523104bc6f39b0c1de3d152d1"><gtr:id>88ac149523104bc6f39b0c1de3d152d1</gtr:id><gtr:otherNames>Elliott KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>pm_16670_20_22956599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC9A3045-948D-4313-A7EF-92E5A64F0EA7</gtr:id><gtr:title>Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.</gtr:title><gtr:parentPublicationTitle>Genetics in medicine : official journal of the American College of Medical Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b8888fe632202324e289dff1e8c0394"><gtr:id>1b8888fe632202324e289dff1e8c0394</gtr:id><gtr:otherNames>Robbe P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1098-3600</gtr:issn><gtr:outcomeId>5a9d51ffd7d322.78368068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E50D5F9A-3C0F-450E-901D-9DA9BF936FA1</gtr:id><gtr:title>Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf701a8f3e746fa6cdbab8e1399f7fb8"><gtr:id>bf701a8f3e746fa6cdbab8e1399f7fb8</gtr:id><gtr:otherNames>Randall JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_13563_23_23754948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA851204-EA0F-43CA-8C9E-603183F20926</gtr:id><gtr:title>Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe41a7ffa856ed36e739a0a32de3913"><gtr:id>fbe41a7ffa856ed36e739a0a32de3913</gtr:id><gtr:otherNames>Chinoy H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>pm_16670_20_22186711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F37978F1-D82E-4260-A639-D3EFE1C1274F</gtr:id><gtr:title>Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e9d35205ffb3f2f72af0d4dab578e"><gtr:id>a32e9d35205ffb3f2f72af0d4dab578e</gtr:id><gtr:otherNames>Tachmazidou I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5aaa64e8d62016.43336658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA9278B5-8B59-4E2C-902F-BF92844A3D2D</gtr:id><gtr:title>A selective sweep of &amp;gt;8 Mb on chromosome 26 in the Boxer genome.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8569845fc1086e1a3fdfc9bd1384ec8a"><gtr:id>8569845fc1086e1a3fdfc9bd1384ec8a</gtr:id><gtr:otherNames>Quilez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>pm_16670_20_21722374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD87ACD0-9A0F-4B05-8965-07634B4718CD</gtr:id><gtr:title>A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood Pressure.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed20ddd4f5e1abb58fe902a40d6f4af0"><gtr:id>ed20ddd4f5e1abb58fe902a40d6f4af0</gtr:id><gtr:otherNames>Sung YJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5a9d51ff48d191.70910541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28A105A0-3039-47D6-92F2-404A905F9E5E</gtr:id><gtr:title>Genome-wide autozygosity is associated with lower general cognitive ability.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dd4a0d4b36eb8675ebbc77052268875"><gtr:id>0dd4a0d4b36eb8675ebbc77052268875</gtr:id><gtr:otherNames>Howrigan DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>56e058618c5a13.05147021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EE3B549-9C46-4AB9-8D1A-C9A711692AED</gtr:id><gtr:title>Biallelic Mutation of ARHGEF18, Involved in the Determination of Epithelial Apicobasal Polarity, Causes Adult-Onset Retinal Degeneration.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88f016512e3e841e2f352e85bc2a6c1d"><gtr:id>88f016512e3e841e2f352e85bc2a6c1d</gtr:id><gtr:otherNames>Arno G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5a9d5205743d18.39143135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4164FFF6-3DD7-42AA-9CDA-CB81CD5BDEA0</gtr:id><gtr:title>Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9947425478818f3f056819b465ff20bf"><gtr:id>9947425478818f3f056819b465ff20bf</gtr:id><gtr:otherNames>Jani M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>56e0582a49b857.97845358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0CC182F-F14E-48E0-9943-7EF545CB6752</gtr:id><gtr:title>Evaluation of shared genetic aetiology between osteoarthritis and bone mineral density identifies SMAD3 as a novel osteoarthritis risk locus.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05a4d5904008a95d663bd45423c5711"><gtr:id>f05a4d5904008a95d663bd45423c5711</gtr:id><gtr:otherNames>Hackinger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5aaa64e88de6d7.97589297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A65250AB-9944-43A1-8D17-6D44D75A86DD</gtr:id><gtr:title>Mutations in the TGF-? repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4297d28bf106a488fb65510b6434eb2"><gtr:id>f4297d28bf106a488fb65510b6434eb2</gtr:id><gtr:otherNames>Doyle AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13563_23_23023332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52D0076D-6D79-4FD8-A880-B8B8622430BA</gtr:id><gtr:title>Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87d790de652f8364d93c11ebda0e9ec4"><gtr:id>87d790de652f8364d93c11ebda0e9ec4</gtr:id><gtr:otherNames>Pattaro C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58b814b4d3c567.59757895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D1535BA-4623-490D-B1F2-E6B580388395</gtr:id><gtr:title>Evolutionary conserved longevity genes and human cognitive abilities in elderly cohorts.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c384ffe8eb1b13d2d32fbeaba30ec6"><gtr:id>90c384ffe8eb1b13d2d32fbeaba30ec6</gtr:id><gtr:otherNames>Lopez LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>pm_16670_20_22045296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F057F1D-26E6-489C-8CDB-D5D3235D84B7</gtr:id><gtr:title>Analysis with the exome array identifies multiple new independent variants in lipid loci.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69dea32a060ad338472db49f9e53b2d8"><gtr:id>69dea32a060ad338472db49f9e53b2d8</gtr:id><gtr:otherNames>Kanoni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58b814b483c589.17645647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>257CE3F6-D313-4E88-8D69-486FD7BE694F</gtr:id><gtr:title>Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a52ffd9a4a4bad60a58cb8d90aa9bcac"><gtr:id>a52ffd9a4a4bad60a58cb8d90aa9bcac</gtr:id><gtr:otherNames>de Tute R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn><gtr:outcomeId>46B983F02E7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C36DEDCE-6974-4100-A6C8-8C7F35ECDCD7</gtr:id><gtr:title>No association between apolipoprotein E or N-acetyltransferase 2 gene polymorphisms and age-related hearing loss.</gtr:title><gtr:parentPublicationTitle>The Laryngoscope</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aa4eb60063232735e6f68ff96a381be"><gtr:id>9aa4eb60063232735e6f68ff96a381be</gtr:id><gtr:otherNames>Dawes P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0023-852X</gtr:issn><gtr:outcomeId>56e05d9236c811.57986484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B10E2BED-3BBD-418B-B2F4-786DCF5CFC77</gtr:id><gtr:title>Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations With Midlife Blood Pressure Levels and Cardiovascular Events.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ff2c6ea5887a6f679a967cc0e9931e2"><gtr:id>0ff2c6ea5887a6f679a967cc0e9931e2</gtr:id><gtr:otherNames>Pazoki R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>5a9d52014fd0f9.68103968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D798388D-BDEA-4601-ACFD-72AE39AF19EE</gtr:id><gtr:title>Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64cc8aa80998d2dd3dcc4e0b26c3208f"><gtr:id>64cc8aa80998d2dd3dcc4e0b26c3208f</gtr:id><gtr:otherNames>Dale CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>5a9d520480fbd6.96149839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>794E9CD0-4AC1-4A60-952F-FE885FEC61BA</gtr:id><gtr:title>Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10a99866f7b13a77e5429d4ee9ca8c09"><gtr:id>10a99866f7b13a77e5429d4ee9ca8c09</gtr:id><gtr:otherNames>Warren HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b814b297d031.82176416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD669392-456E-4863-87C5-D73D6E21480A</gtr:id><gtr:title>Radiographic endophenotyping in hip osteoarthritis improves the precision of genetic association analysis.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/563604aabe18251ac9670f0a95ca4c98"><gtr:id>563604aabe18251ac9670f0a95ca4c98</gtr:id><gtr:otherNames>Panoutsopoulou K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>5aaa64e9748817.26031728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F963C95-0DF3-4CEE-8B97-411CCB601D27</gtr:id><gtr:title>Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10eb4ed5eca6b05db540125a1dbe8e14"><gtr:id>10eb4ed5eca6b05db540125a1dbe8e14</gtr:id><gtr:otherNames>Lam M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aaa64e4f11f96.44989697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E7E0444-E23F-4EBD-AC64-7037295A4D1C</gtr:id><gtr:title>Identification of a mutation associated with fatal Foal Immunodeficiency Syndrome in the Fell and Dales pony.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04f8e95e591fd8a1d96756d6583bc66c"><gtr:id>04f8e95e591fd8a1d96756d6583bc66c</gtr:id><gtr:otherNames>Fox-Clipsham LY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_16670_20_21750681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72E66AA9-9F16-43B3-BC3A-2864FB3DE8CF</gtr:id><gtr:title>Restricted dog leucocyte antigen (DLA) class II haplotypes and genotypes in Beagles.</gtr:title><gtr:parentPublicationTitle>Veterinary journal (London, England : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0e62e56bf11c1766e884c2df54af972"><gtr:id>d0e62e56bf11c1766e884c2df54af972</gtr:id><gtr:otherNames>Soutter F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1090-0233</gtr:issn><gtr:outcomeId>56e05e26128c82.10511340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A153A0A-A1B9-40E6-B6B5-0FC74703AF03</gtr:id><gtr:title>Route to improving Type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit.</gtr:title><gtr:parentPublicationTitle>Diabetic medicine : a journal of the British Diabetic Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7eb127f47da648327fb98b100b3635d8"><gtr:id>7eb127f47da648327fb98b100b3635d8</gtr:id><gtr:otherNames>Heald AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn><gtr:outcomeId>5aaa64e5459123.86419115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05475E95-D682-42B5-99F9-A9BC214A0896</gtr:id><gtr:title>Familial chronic lymphocytic leukemia in Norway and Denmark. Comments on pleiotropy and birth order.</gtr:title><gtr:parentPublicationTitle>In vivo (Athens, Greece)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce77a2d7bab1bb5f89f650ba9b78317c"><gtr:id>ce77a2d7bab1bb5f89f650ba9b78317c</gtr:id><gtr:otherNames>J?nsson V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0258-851X</gtr:issn><gtr:outcomeId>K8kdLZwKf6n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C58C7A8-EF6A-4BEE-AEB0-B057AE31B92B</gtr:id><gtr:title>Genome-wide analysis of blood pressure variability and ischemic stroke.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd8ab34f59180cdb6c4e8422460c89d6"><gtr:id>dd8ab34f59180cdb6c4e8422460c89d6</gtr:id><gtr:otherNames>Yadav S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_13563_23_23929743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5F5095B-0E87-4E09-8759-9B797582C8AE</gtr:id><gtr:title>New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68eb155a9ee1ab90ba650ebb423d8356"><gtr:id>68eb155a9ee1ab90ba650ebb423d8356</gtr:id><gtr:otherNames>Kraja AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>5a9d5202bda837.37015767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBA448E5-9ED9-4969-988D-770D405BBE19</gtr:id><gtr:title>Advances in blood pressure genomics.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/490fed85c84528133103e9ef4adcdc76"><gtr:id>490fed85c84528133103e9ef4adcdc76</gtr:id><gtr:otherNames>Munroe PB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>pm_13563_23_23661711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7AEAD78-57EC-471C-B827-77AD874B440E</gtr:id><gtr:title>Infrastructure vital to genome success.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdc4dcc726a87babd2e7d3f602462e8c"><gtr:id>bdc4dcc726a87babd2e7d3f602462e8c</gtr:id><gtr:otherNames>Yuille M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>FZWobBSQqVF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA76F8CB-1E79-4183-8628-FB4F8FEC75FC</gtr:id><gtr:title>Exome-wide association study of plasma lipids in &amp;gt;300,000 individuals.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5bd460d7c4191ca576be5ee64e1baf7"><gtr:id>e5bd460d7c4191ca576be5ee64e1baf7</gtr:id><gtr:otherNames>Liu DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a9d520201ab72.80399165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>661288B1-7075-4FB9-9A6B-45FD1F89B6E6</gtr:id><gtr:title>POLARIS: Polygenic LD-adjusted risk score approach for set-based analysis of GWAS data.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e508f5607fa23a12fe8e07e33aecec6"><gtr:id>3e508f5607fa23a12fe8e07e33aecec6</gtr:id><gtr:otherNames>Baker E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn><gtr:outcomeId>5aaa5ab2eed244.31460272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D86F953D-E9F0-4CA0-9BE0-7F16EC03CA47</gtr:id><gtr:title>Genome-wide association uncovers shared genetic effects among personality traits and mood states.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a9182b2ee4ce0895db9db0842c40332"><gtr:id>8a9182b2ee4ce0895db9db0842c40332</gtr:id><gtr:otherNames>Luciano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_16670_20_22628180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E363D1A-753D-429E-8602-9C60C0248E26</gtr:id><gtr:title>Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane Aformation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b16d97e3a219d25a3f672cd807f573fe"><gtr:id>b16d97e3a219d25a3f672cd807f573fe</gtr:id><gtr:otherNames>McCarthy NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>5a9d5200f1e2e7.71887386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98E5C8A7-A983-452B-9514-1DDA1E2A1EEA</gtr:id><gtr:title>Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2c39afe845e351135709b4da8652d2f"><gtr:id>f2c39afe845e351135709b4da8652d2f</gtr:id><gtr:otherNames>Berndt SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13563_23_23563607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E5992B6-4D2E-4482-B959-10FF02123AE0</gtr:id><gtr:title>Identification of genomic regions associated with phenotypic variation between dog breeds using selection mapping.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbaf7410929717b45119429f6930c87c"><gtr:id>cbaf7410929717b45119429f6930c87c</gtr:id><gtr:otherNames>Vaysse A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_16670_20_22022279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE2EB863-5FAD-468B-A0E5-32830AF5E021</gtr:id><gtr:title>Laboratory management of samples in biobanks: European consensus expert group report.</gtr:title><gtr:parentPublicationTitle>Biopreservation and biobanking</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdc4dcc726a87babd2e7d3f602462e8c"><gtr:id>bdc4dcc726a87babd2e7d3f602462e8c</gtr:id><gtr:otherNames>Yuille M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1947-5543</gtr:issn><gtr:outcomeId>ZdYWpw5DvwU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B897AB75-4692-4948-B316-8722429D021F</gtr:id><gtr:title>Molecular medicine ireland guidelines for standardized biobanking.</gtr:title><gtr:parentPublicationTitle>Biopreservation and biobanking</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce1b7cf85390d9551608a9b1de3e6dc"><gtr:id>8ce1b7cf85390d9551608a9b1de3e6dc</gtr:id><gtr:otherNames>Guerin JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1947-5543</gtr:issn><gtr:outcomeId>o3e5TMNTSYN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55D30F7A-A11F-4477-B086-57C771328A5B</gtr:id><gtr:title>Increased NBCn1 expression, Na+/HCO3- co-transport and intracellular pH in human vascular smooth muscle cells with a risk allele for hypertension.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80c16835b332272f8c178d01a34d8a3b"><gtr:id>80c16835b332272f8c178d01a34d8a3b</gtr:id><gtr:otherNames>Ng FL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58b814b2d64511.36382248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58BE28CA-B500-4AB9-8075-E3EB0EDBA715</gtr:id><gtr:title>Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0aabcf3318f5a7b593a0ea7608a3439b"><gtr:id>0aabcf3318f5a7b593a0ea7608a3439b</gtr:id><gtr:otherNames>Postmus I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>58b814b453dd20.44810123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>440B1CE2-3E8D-47BA-86FB-460A03C1A8F4</gtr:id><gtr:title>Comprehensive catalog of European biobanks.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a340e639801a1ed725f7c06ac5657ad7"><gtr:id>a340e639801a1ed725f7c06ac5657ad7</gtr:id><gtr:otherNames>Wichmann HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>sBPrEncgNmG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E28F306-8600-4B17-B998-1F4F743EF845</gtr:id><gtr:title>Randomised, double-blind, placebo-controlled study investigating the effects of inorganic nitrate on vascular function, platelet reactivity and restenosis in stable angina: protocol of the NITRATE-OCT study.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70018f9d9f7c4a600984bcc360c6decb"><gtr:id>70018f9d9f7c4a600984bcc360c6decb</gtr:id><gtr:otherNames>Rathod KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>58b814b3107d30.64641075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D66C8A8-C3F4-4944-8693-D80370A2E5A1</gtr:id><gtr:title>The EuroMyositis registry: an international collaborative tool to facilitate myositis research.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14bd64c16502c520af788739a29cb702"><gtr:id>14bd64c16502c520af788739a29cb702</gtr:id><gtr:otherNames>Lilleker JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>5aaa64e62b68a9.51531898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1574A665-7EE2-45F4-9CF5-82FB1ECA5169</gtr:id><gtr:title>Genome-wide association study identifies genomic regions of association for cruciate ligament rupture in Newfoundland dogs.</gtr:title><gtr:parentPublicationTitle>Animal genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10fe29bc65d5fcb8f335c43b0c42c07d"><gtr:id>10fe29bc65d5fcb8f335c43b0c42c07d</gtr:id><gtr:otherNames>Baird AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0268-9146</gtr:issn><gtr:outcomeId>56e05e54707848.53011670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3410F640-5977-4F3C-BE43-E8D45BC6FF3F</gtr:id><gtr:title>Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d650d10593bac5fd741f0c8a365fc160"><gtr:id>d650d10593bac5fd741f0c8a365fc160</gtr:id><gtr:otherNames>Rothwell S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>56e057464da686.98571636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4527B5A2-62CB-4020-A38F-B262E98223F1</gtr:id><gtr:title>No evidence of an association between mitochondrial DNA variants and osteoarthritis in 7393 cases and 5122 controls.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>pm_16670_20_22984172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84EF58D4-F2BE-4E3F-B424-4986CC7BE721</gtr:id><gtr:title>Biobanking for Europe.</gtr:title><gtr:parentPublicationTitle>Briefings in bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdc4dcc726a87babd2e7d3f602462e8c"><gtr:id>bdc4dcc726a87babd2e7d3f602462e8c</gtr:id><gtr:otherNames>Yuille M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1467-5463</gtr:issn><gtr:outcomeId>412F22263E1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF88BD0A-FF23-4B42-956E-2185F88CF0B0</gtr:id><gtr:title>Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9f23628f161ce7bf812289c275c58a7"><gtr:id>d9f23628f161ce7bf812289c275c58a7</gtr:id><gtr:otherNames>Peters MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>pm_16670_20_22956598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63DC9E84-333B-47C1-9163-9392403338A0</gtr:id><gtr:title>Genes for blood pressure: an opportunity to understand hypertension.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f460767649781454eba53de21a508d00"><gtr:id>f460767649781454eba53de21a508d00</gtr:id><gtr:otherNames>Ehret GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>pm_13563_23_23303660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3CF80CB-1EC0-4396-A2FF-9C53BCEB85B7</gtr:id><gtr:title>Investigation of a functional quinine oxidoreductase (NQO2) polymorphism and cognitive decline.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed898e47279e6b3474fdade1f119de7d"><gtr:id>ed898e47279e6b3474fdade1f119de7d</gtr:id><gtr:otherNames>Payton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>oy1mVyc715V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>791F89D7-ABC1-4A57-8FFC-2433BA2AEF22</gtr:id><gtr:title>The role of ECE1 variants in cognitive ability in old age and Alzheimer's disease risk.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3d9dd16ce35d2096b37dfc9199bc7"><gtr:id>69c3d9dd16ce35d2096b37dfc9199bc7</gtr:id><gtr:otherNames>Hamilton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_16670_20_22693153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83BB491C-11A0-4005-ADF9-B138A8C78871</gtr:id><gtr:title>The biological impact of blood pressure-associated genetic variants in the natriuretic peptide receptor C gene on human vascular smooth muscle.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55a72d974dd354a2b437211c97edf065"><gtr:id>55a72d974dd354a2b437211c97edf065</gtr:id><gtr:otherNames>Ren M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a9d520270d562.41304605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D2F45FF-B854-48AE-863B-BA91FDBE853E</gtr:id><gtr:title>Common polymorphisms in the CYP11B1 and CYP11B2 genes: evidence for a digenic influence on hypertension.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc470cd2f13415638d337587c37a73f5"><gtr:id>bc470cd2f13415638d337587c37a73f5</gtr:id><gtr:otherNames>Alvarez-Madrazo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>pm_13563_23_23150505</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6550C223-C167-4A82-BC41-8A91CDB788D3</gtr:id><gtr:title>Rare and low-frequency coding variants alter human adult height.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e375f8da269c5aef74fdc314da8bf29d"><gtr:id>e375f8da269c5aef74fdc314da8bf29d</gtr:id><gtr:otherNames>Marouli E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58b814b24f0211.78757987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75C6E219-0794-4BD7-9768-B42DDA52DE09</gtr:id><gtr:title>Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51af9c896d681ece29bfb49215750405"><gtr:id>51af9c896d681ece29bfb49215750405</gtr:id><gtr:otherNames>arcOGEN Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_16670_20_22763110</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600237</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>